In the global pharmaceutical industry, there were 430 M&A deals announced in Q1 2024, worth a total value of $68.8bn, according to GlobalData’s Deals Database. The $16.5bn acquisition of Catalent by Novo Holdings was the industry’s largest disclosed deal. In value terms, M&A activity decreased by 17% in Q1 2024 compared with the previous quarter’s total of $82.8bn and fell by 7% as compared to Q1 2023. Related deal volume decreased by 5% in Q1 2024 versus the previous quarter and was 4% higher than in Q1 2023.
Read the full article: How Did M&A Perform in Pharmaceuticals in Q1 2024? //
Source: https://www.pharmaceutical-technology.com/data-insights/global-ma-activity-pharmaceutical-industry/